Unibest

Pharmaceutical intermediates

Suzetrigine Intermediates

10 pharmaceutical intermediates for Suzetrigine. Indication: Pain.

About Suzetrigine

Originator
Vertex Pharmaceuticals Inc
Indication
Pain
Approved Date
01/30/2025
NCE Patent
01/30/2030
DS/DP
12/04/2040

Available intermediates

10 intermediates currently listed for Suzetrigine. Request specifications, documentation or a quotation for any item below.

Suzetrigine intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
3,4-Difluoro-2-methoxyphenylacetic acid1558274-26-2//
(R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPIONIC ACID44864-47-3//
Methyl 4-aminopyridine-2-carboxylate71469-93-7//
2-Butanone, 4,4,4-trifluoro-3-hydroxy-3-methyl-, (3R)-2875067-31-3//
2-Furancarboxylic acid, 3-(3,4-difluoro-2-methoxyphenyl)tetrahydro-4,5-dimethyl-5-(trifluoromethyl)-, (2R,3S,4S,5R)-2649470-87-9//
(2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-carboxylic acid (R)-1-phenylethan-1-amine salt2649470-89-1//
(2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-carbonitrile2875067-17-5//
2(5H)-Furanone, 3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)-, (5R)-2875066-35-4//
Methyl 4-[[[(2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)tetrahydro-4,5-dimethyl-5-(trifluoromethyl)-2-furanyl]carbonyl]amino]-2-pyridinecarboxylate2879218-02-5//
2-Pyridinecarboxamide, 4-[[[(2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)tetrahydro-4,5-dimethyl-5-(trifluoromethyl)-2-furanyl]carbonyl]amino]-2649467-58-1//

Building toward Suzetrigine?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

我们能如何帮助您?

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →